Search

Your search keyword '"BURIONI , ROBERTO"' showing total 404 results

Search Constraints

Start Over You searched for: Author "BURIONI , ROBERTO" Remove constraint Author: "BURIONI , ROBERTO" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
404 results on '"BURIONI , ROBERTO"'

Search Results

Catalog

Books, media, physical & digital resources

3. Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmission and facilitates serum-mediated enhancement.

4. High Prevalence of High-Risk HPV Among People with and Without HIV: Insights into Risk Factors for Tailored Screening Approaches.

5. Breakthrough Rectal Neisseria gonorrhoeae Infections After Meningococcal B Vaccination: Microbiological and Clinical Features.

6. The Effectiveness of COVID-19 Vaccines During the Pre-Omicron and Omicron Periods: A Retrospective Test-Negative Case–Control Study.

12. Enteric Microbiome Markers as Early Predictors of Clinical Outcome in Allogeneic Hematopoietic Stem Cell Transplant: Results of a Prospective Study in Adult Patients

13. A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation

15. Lessons from Italy's policy shift on immunization

25. Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity

29. Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle

33. Differential Composition of Vaginal Microbiome, but Not of Seminal Microbiome, Is Associated With Successful Intrauterine Insemination in Couples With Idiopathic Infertility: A Prospective Observational Study

36. Answer to February 2019 Photo Quiz

37. Intracytoplasmic stable expression of IgG1 antibody targeting NS3 helicase inhibits replication of highly efficient hepatitis C Virus 2a clone

38. Dynamic features of the selective pressure on the human immunodeficiency virus type 1 (HIV-1) gp120 CD4-binding site in a group of long term non progressor (LTNP) subjects

39. Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge

41. Role and potential therapeutic use of antibodies against herpetic infections

42. Influenza B-Cells Protective Epitope Characterization: A Passkey for the Rational Design of New Broad-Range Anti-Influenza Vaccines

44. Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes

45. Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein

46. A closer look at prion strains

47. A Biologically-validated HCV E1E2 Heterodimer Structural Model

49. Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools

50. Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens